The question for biomanufacturing leaders is no longer whether to modernize their scientific data infrastructure, but how ...

Boltz-2 is the latest milestone in MIT Jameel Clinic’s growing portfolio of open-source tools for health, developed at the ...

Antibody-drug conjugates (ADCs) hit the scene in oncology many moons ago – in fact, this year marks 25 years since the first ...

Speaking at BIO2025, rare disease leaders from Ultragenyx, Amylyx and Yale questioned the need for the new regulatory pathway ...

Novo Nordisk has launched Wegovy in India, a weight-loss drug challenging Eli Lilly's Mounjaro. Available by June 2025, ...

Within the broader economic vision for Vietnam’s private sector, the pharmaceutical industry, an inherently sensitive and ...

IonQ, a leading quantum technology company, has announced a record-breaking advancement in protein folding, a critical ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

A machine meant to extend the shelf life of Hawaiʻi-grown products hasn't been used in the year it's been at the Wahiawā ...

Tailoring medicines to an individual’s genetic profile is now possible. One critical aspect is genetic testing that reduces ...

In 1991, research nurse Karen Rapp was hired by the UC San Diego Stroke Center to oversee a new clinical trial. The goal: to ...